Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart's electrical angle may forecast brain bleed survival

NCT ID NCT07196891

Knowledge-focused Sponsor: Haseki Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Researchers studied 354 adults who came to the emergency room with a brain aneurysm rupture. They looked at a specific measurement from a standard ECG, called the frontal QRS/T angle, to see if it could predict who would die within 28 days or have lasting brain damage. The goal was to find a quick, bedside tool to help doctors gauge severity early on.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the ECG angle proves reliable, it could give doctors a quick, non-invasive way to estimate a patient's risk right after a brain bleed.
What could go wrong
This is a single-center, observational study, not a treatment trial. The ECG measure may not be accurate enough to change care, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

354 people

The number who actually took part.

Started

Jul 2020

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This multicenter, retrospective, observational cohort study enrolled 354 consecutive adult patients (aged ≥ 18 years) who presented to the emergency departments of the seven major and highest-volume tertiary hospitals in Istanbul with non-traumatic Subarachnoid Hemorrhage between July 2020 and July 2025. Data were collected by searching for I60.9 International Classification of Diseases (ICD) codes in the hospital's automation systems and archives.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- patients (aged ≥ 18 years) who presented to the emergency department with non-traumatic Subarachnoid Hemorrhage between July 2020 and July 2025 Exclusion Criteria: * patients younger than 18 years * patients with missing information * patients with traumatic SAH * patients with subdural or epidural hemorrhage * patients with concurrent ischemic stroke

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Subarachnoid hemorrhage, aneurysmal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Subarachnoid hemorrhage, aneurysmal

Contacts and locations

Locations

  • Haseki Training and Research Hospital

    Istanbul, Fatih, 34265, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.